BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND APOBEC3B, ARP4, 9582, ENSG00000179750, DJ742C19_2, _phorbolin 3_, PHRBNL, FLJ21201, Q9UH17, bK150C2_2, APOBEC1L, ARCD3 AND Treatment
14483 results:

  • 1. CXCL10 and IL15 co-expressing chimeric antigen receptor T cells enhance anti-tumor effects in gastric cancer by increasing cytotoxic effector cell accumulation and survival.
    Nie S; Song Y; Hu K; Zu W; Zhang F; Chen L; Ma Q; Zhou Z; Jiao S
    Oncoimmunology; 2024; 13(1):2358590. PubMed ID: 38812569
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Helicobacter pylori treatment and gastric cancer Risk Among Individuals With High Genetic Risk for gastric cancer.
    Xu HM; Han Y; Liu ZC; Yin ZY; Wang MY; Yu C; Ma JL; Sun D; Liu WD; Zhang Y; Zhou T; Zhang JY; Pei P; Yang L; Millwood IY; Walters RG; Chen Y; Du H; Chen Z; You WC; Li L; Pan KF; Lv J; Li WQ
    JAMA Netw Open; 2024 May; 7(5):e2413708. PubMed ID: 38809553
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.
    Qiu MZ; Oh DY; Kato K; Arkenau T; Tabernero J; Correa MC; Zimina AV; Bai Y; Shi J; Lee KW; Wang J; Poddubskaya E; Pan H; Rha SY; Zhang R; Hirano H; Spigel D; Yamaguchi K; Chao Y; Wyrwicz L; Disel U; Cid RP; Fornaro L; Evesque L; Wang H; Xu Y; Li J; Sheng T; Yang S; Li L; Moehler M; Xu RH;
    BMJ; 2024 May; 385():e078876. PubMed ID: 38806195
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Chinese Medicine Prolongs Overall Survival of Chinese Patients with Advanced gastric cancer: treatment Pattern and Survival Analysis of a 20-Year Real-World Study.
    Cao ND; Zhu XH; Ma FQ; Xu Y; Dong JH; Qin MM; Liu TS; Zhu CC; Guo WJ; Ding HH; Guo YB; Liu LK; Song JJ; Wu JP; Cheng YL; Zeng L; Zhao AG
    Chin J Integr Med; 2024 Jun; 30(6):489-498. PubMed ID: 38801641
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effect of anti-claudin 18.2 monoclonal antibody zolbetuximab alone or combined with chemotherapy or programmed cell death-1 blockade in syngeneic and xenograft gastric cancer models.
    Nishibata T; Weng J; Omori K; Sato Y; Nakazawa T; Suzuki T; Yamada T; Nakajo I; Kinugasa F; Türeci Ö; Şahin U; Yoshida T
    J Pharmacol Sci; 2024 Jul; 155(3):84-93. PubMed ID: 38797537
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. EGFR and PI3K Signalling Pathways as Promising Targets on Circulating Tumour Cells from Patients with Metastatic gastric Adenocarcinoma.
    Piper AK; Penney C; Holliday J; Tincknell G; Ma Y; Napaki S; Pantel K; Brungs D; Ranson M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791602
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Advances in Diagnostic, Staging, and Restaging Evaluation of Esophageal and gastric cancer.
    Nobel T; Sihag S
    Surg Oncol Clin N Am; 2024 Jul; 33(3):467-485. PubMed ID: 38789190
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Immunohistochemical Human Epidermal Growth Factor Receptor 2 (HER2) Expression Pattern in gastric Adenocarcinomas in a Nigerian Tertiary Hospital.
    Mashor MI; Ezenkwa US; Ogun GO; Ajani MA; Ogunbiyi JO
    West Afr J Med; 2024 Mar; 41(3):311-316. PubMed ID: 38788150
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The efficacy and safety of apatinib combined with S-1 for advanced gastric cancer: A systematic review and meta-analysis.
    Chen X; Wan L; He Y; Zhang Q; Zheng X
    Medicine (Baltimore); 2024 May; 103(21):e38272. PubMed ID: 38787998
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomach.
    Bollschweiler E; Hölscher AH; Markar SR; Alakus H; Drebber U; Mönig SP; Plum PS
    Cancer Med; 2024 May; 13(10):e7223. PubMed ID: 38778711
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. State-of-the-Art Advancements in Gastroesophageal cancer treatment: Harnessing Biomarkers for Precision Care.
    Balmaceda NB; Petrillo A; Krishnan M; Zhao JJ; Kim S; Klute KA; Sundar R
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e431060. PubMed ID: 38771996
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Impact of the number of therapy lines on survival in advanced gastric and esophagogastric adenocarcinoma - a real-world retrospective analysis from Croatia.
    Bišof V; Katić A; Soče M; Vidović M; Viculin J; Pleština S; Vrdoljak E
    Neoplasma; 2024 Apr; 71(2):201-208. PubMed ID: 38766850
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
    Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clip-and-snare method with a pre-looping technique versus conventional method in the treatment of precancerous lesion and early gastric cancer: a retrospective study.
    Deng R; Wu J; Li D; Wu B; Shi R; Tian Y; Yao J; Wang LS
    BMC Gastroenterol; 2024 May; 24(1):170. PubMed ID: 38760726
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced gastric cancer.
    Yamaguchi K; Ito M; Isobe T; Koreishi S; Taguchi R; Uehara K; Ueno S; Imajima T; Kitazono T; Tsuchihashi K; Ohmura H; Yoshihiro T; Tanoue K; Nishiyori S; Iwama E; Maeda T; Akashi K; Baba E
    JCO Precis Oncol; 2024 May; 8():e2300681. PubMed ID: 38748981
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Clinical characteristics and prognosis analysis of gastric cancer patients with bone metastasis].
    Zhang MM; Lai M; Li YT; An Y; Yuan WZ
    Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):438-448. PubMed ID: 38742357
    [No Abstract]    [Full Text] [Related]  

  • 17. Nutritional responsiveness affects novel neutrophil parameters and reduces in-hospital mortality and costs in elective cancer oesophagectomy - a single centre, prospective, observational study.
    Kutnik P; Borys M; Nurczyk K; Domerecka W; Dziedzic J; Buszewicz G; Teresiński G; Donica H; Piwowarczyk P; Czuczwar M
    Anaesthesiol Intensive Ther; 2024; 56(1):77-82. PubMed ID: 38741447
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Low prognostic nutrition index as a prognostic biomarker in elderly patients with early gastric cancer after gastrectomy.
    Takahashi T; Kaneoka Y; Maeda A; Takayama Y; Aoyama H; Hosoi T; Seita K
    J Med Invest; 2024; 71(1.2):113-120. PubMed ID: 38735706
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Evaluation of the cytotoxic activities of the essential oil from Pistacia atlantica Desf. oleoresin on human gastric cancer cell lines.
    Saeedi F; Salehi M; Kamali MJ; Mir MA; Kazemi S; Shirafkan F; Neyshaburi EZ; Moeeni R; Gorji N; Memariani Z
    Med Oncol; 2024 May; 41(6):148. PubMed ID: 38733486
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. An In Vitro Study on the Cytotoxic, Antioxidant, and Antimicrobial Properties of Yamogenin-A Plant Steroidal Saponin and Evaluation of Its Mechanism of Action in gastric cancer Cells.
    Stefanowicz-Hajduk J; Graczyk P; Hering A; Gucwa M; Nowak A; Hałasa R
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731847
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 725.